The new 4-quinolones DU-6859a and DV-7751a show enhanced activity against Streptococcus pneumoniae.
Morrissey
I
I
Chemotherapy Research Unit, University of East London, England.
Smith
J T
JT
D000890:Anti-Infective Agents / Q000494:pharmacology*; D003470:Culture Media; D004352:Drug Resistance, Microbial; D024841:Fluoroquinolones; D008826:Microbial Sensitivity Tests; D015242:Ofloxacin / Q000494:pharmacology; D015363:Quinolones / Q000494:pharmacology*; D013141:Spiro Compounds / Q000494:pharmacology*; D013296:Streptococcus pneumoniae / Q000187:drug effects*
D000890:Anti-Infective Agents; D003470:Culture Media; D024841:Fluoroquinolones; D015363:Quinolones; D013141:Spiro Compounds; C084755:DV 7751a; C076246:sitafloxacin; D015242:Ofloxacin